Top Biotechnology & Medical Research stocks in Australia
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
TLXTelix Pharmaceuticals | AU$4.83bn | 841.9 | n/a |
MSBMesoblast | AU$943.76m | n/a | n/a |
CU6Clarity Pharmaceuticals | AU$685.88m | n/a | n/a |
IMUImugene | AU$566.36m | n/a | n/a |
IMMImmutep | AU$499.31m | n/a | n/a |
OPTOpthea | AU$414.26m | n/a | n/a |
PYCPYC Therapeutics | AU$343.42m | n/a | n/a |
CGSCogstate | AU$234.78m | 30.26 | n/a |
RACRace Oncology | AU$214.18m | n/a | n/a |
DXBDimerix | AU$136.38m | n/a | n/a |
PIQProteomics International Laboratories | AU$133.96m | n/a | n/a |
ALAArovella Therapeutics | AU$109.16m | n/a | n/a |
PARParadigm Biopharmaceuticals | AU$94.90m | n/a | n/a |
OCCOrthocell | AU$74.73m | n/a | n/a |
ACWActinogen Medical | AU$69.22m | n/a | n/a |
PERPercheron Therapeutics | AU$61.31m | n/a | n/a |
AGNArgenica Therapeutics | AU$56.02m | n/a | n/a |
BITBiotron | AU$55.02m | n/a | n/a |
ADOAnteotech | AU$50.52m | n/a | n/a |
IIQInoviq | AU$48.31m | n/a | n/a |